According to the Scleroderma Foundation, scleroderma is a chronic systemic autoimmune disease characterized by hardening (sclero) of the skin (derma), though it may also affect other organs. There is still no cure for scleroderma but effective treatments for some forms of the disease are available. It can be…
Image
According to the Cleveland Clinic, although scleroderma may be similar in adults and children, there are some specific characteristics that are more pronounced in children. Pediatric scleroderma is divided into systemic and localized diseases, which is further differentiated into subtypes based on clinical findings of skin involvement.
Scleroderma renal crisis a problem that may occur in patients who suffer from scleroderma — an autoimmune condition that causes an overproduction and accumulation of collagen in the tissue, affecting the skin and internal organs, including the kidneys. In this Demystifying Medicine video from McMaster University, learn more about this rare…
10 Facts and Statistics About Autoimmune Diseases
An autoimmune disorder occurs when the body’s immune system malfunctions. It mistakenly identifies healthy cells as foreign cells and starts attacking and destroying them. Scleroderma is just one of many autoimmune diseases. It’s a chronic rheumatic disease that affects the body by hardening connective tissue. MORE: Seven interesting…
Do You Know How Serious Scleroderma Is?
Even though scleroderma affects around 2.5 million people worldwide including 300,000 people in the U.S., it’s a disease that few people know about. The rare autoimmune disease affects the skin and internal organs, but just how serious is it? We’ve put together some information that explains how serious the disease can be, who it affects and…
6 Effects of Chronic Fatigue in Autoimmune Diseases
Autoimmune diseases and chronic fatigue go hand in hand, as anyone with lupus, scleroderma, multiple sclerosis, fibromyalgia, IBD (and a host more) will testify. Chronic fatigue affects daily life and your ability to go about your business. It’s incredibly debilitating and yet, very misunderstood by those who don’t suffer from it. We’ve put…
Scleroderma (SSc) is a rare but progressive autoimmune disease that mainly affects women between the ages of 20 and 50, although men and children can also develop the disease. Many patients who have scleroderma also develop pulmonary arterial hypertension (PAH). MORE: Three possible risks for scleroderma 1. According to the Scleroderma…
6 Tips to Help Control Raynaud’s Phenomenon Flares
For scleroderma patients, Raynaud’s phenomenon symptoms are much more apparent in the winter when the brutal cold takes its toll. However, there are ways to manage the condition that can help sufferers quickly recover from a flare and get the circulation flowing again. MORE: Discover seven common misconceptions about scleroderma. We’ve…
In this special article, Scleroderma News Today‘s resident blogger and scleroderma patient, Nicola Whitehill shares her tips on how to better manage Raynaud’s during a seasonal change. 1. Don’t forget to take your medication. It’s important not to miss any dose of your medication. Try to organize your treatment plan…
Explaining the Long-Term Progression of Scleroderma
This video from FESCA taken at the fourth Systemic Sclerosis World Congress in Lisbon in 2016 shares two presentations dedicated to the progression of scleroderma and how it affects patients on a long-term basis. MORE: Discover six tips for eating well with scleroderma First up is Dr. Jason Lee…
Recent Posts
- Survival improves for SSc-PAH patients on combination therapy
- Combination drug therapy boosts lung, skin health in SSc patients
- On choosing medicine’s side effects over scleroderma progression
- Telerehabilitation improves hand mobility in scleroderma women
- Molecular pathway ID’d as key driver of scarring in scleroderma
- Limited hand function disrupts daily life for people living with SSc
- Coping with loss is part of living with scleroderma
- CAR T-cell therapy eases SSc symptoms, early trial data show
- Milk-derived particles may offer treatment path for SSc fibrosis
- New skin markers help doctors refine dcSSc treatment prognosis